Vous ne pouvez pas vous connecter sans un compte utilisateur TSI valide.
*Merci de noter que cette page est disponible en anglais uniquement.*
The MSP, a Division of TSI, Next Generation Impactor is a high-performance cascade impactor with seven stages.
The NGI is and has been the industry standard pharmaceutical cascade impactor for the last 20 years, with 1800+ units in use and adopted into the USP guidelines. It was designed and developed by and for the OINDP Industry, and is the most efficient and accurate way to do standard in vitro APSD testing. There are many automated and semi-automated add-ons as well as other accessories designed to further improve efficiency.
The NGI+ uses the same industry proven design and substitutes materials to enable a wider range of applications, chemicals, and drugs. The NGI+ provides more corrosion protection, enhanced chemical and biological resistance, and a longer equipment life expectancy for your inhaler testing process. Whether you are testing nebulizers, using biologics, or looking for more robust or even perhaps automated cleaning solutions, the NGI+ expands your options.
(Next Generation Impactor)
(Next Generation Impactor Plus)
(Upgrade existing NGI to the NGI+)
Mensuration and calibration are imperative in pharmaceutical testing, and is recommended by the FDA (Food and Drug Administration), USP (United States Pharmacopeia), and GMP (Good Manufacturing Practices).
Request service today
MSP provides calibration and mensuration services, as well as calibration contracts and extended warranties as part of our QualityGuard™ program.
Each instrument model is unique, please refer to the model-specific service documentation below for details on what each package includes:
Contact the MSP Sales Team (MSPSales@tsi.com) to learn more and order your calibration contract and/or extended warranty by filling out the form below. You can also refer to our QualityGuard ordering brochure for additional detail, including how to ship your equipment to MSP.